Delivery Order SPE2DB20D1050-SPE2DB25FH46V
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,790.90 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.24, is for the delivery of RABAVERT Rabies Vaccine with diluents. This is a Firm Fixed Price Delivery Order contract with a July 2024 completion date. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,029.90, is for the delivery of RABAVERT Rabies Vaccine with Diluents. It is a firm fixed-price contract with an ultimate completion date of August 5, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $54,048.40, has a firm fixed price and an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The $10,616.65 firm fixed price contract has a completion date of November 6, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,837.68 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a period of performance through December 30, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,895.45 firm fixed-price delivery order is for the supply of RABAVERT Rabies Vaccine with diluents, with a completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $41,916.00, is a delivery order contract for the supply of RABAVERT rabies vaccine with diluents. The contract has a final completion date of January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RABAVERT rabies vaccine with diluents. The delivery order, valued at $14,091.19, has a performance period through March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which is part of a larger DLA indefinite delivery contract (IDC) valued up to $999,999,999.00 and running...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...